SHINGARIX owner Contact Information online
from GlaxoSmithKline Biologicals, S.A.
SHINGARIX
US serial number:85169962
Application filling date:Nov. 05, 2010
Register:Principal
Mark type:Trademark
Status:Registered. The registration date is used to determine when post-registration maintenance documents are due.
Status date:Jul. 05, 2011
Publication date:Apr. 19, 2011
Standard character claim:Yes. The mark consists of standard characters without claim to any particular font style, size, or color.
Mark drawing type:4 - STANDARD CHARACTER MARK
Foreign foreign registration number:5849161
Foreign foreign registration date:Mar. 27, 2008
Foreign foreign application registration country:EUROPEAN (EU) OFFICE FOR HARMONIZATION IN THE INTERNAL MARKET (OHIM)
Foreign foreign expiration date:Apr. 23, 2017
Goods and services:For: Vaccines for human use
International Class(es): 005- Primary Class
U.S Class(es): 006,018,044,046,051,052
Class Status: ACTIVE
Basis: 44(e)
Services:Vaccines for human use
Current owner owner name:GlaxoSmithKline Biologicals, S.A.
Current owner owner address:Rue de l'Institut 89
Rixensart
BELGIUM
B1330
Current owner legal entity type:CORPORATION
Current owner state or country:BELGIUM
Attorney name:Angela L. Wilson
Attorney email:trademarks@gsk.com
Attorney email authorized:Yes
Correspondent name address:Angela L. Wilson
GlaxoSmithKline
Five Moore Drive
Legal Global Trademarks, Mailstop: 5.5A
Research Triangle Park,
NORTH CAROLINA
UNITED STATES
27709-0183
Correspondent phone:919.483.0008
Correspondent email:trademarks@gsk.com
Correspondent fax:919.315.3023
Correspondent email authorized:Yes
Domestic representative name:Angela L. Wilson
Domestic representative phone:919.483.0008
Domestic representative fax:919.315.3023
Domestic representative email:trademarks@gsk.com
Domestic representative email authorized SHINGARIX:Yes
Latest trademarks
Popular owners
Glaxo Group Limited (174) Novartis AG (130) JOHNSON & JOHNSON (127) Millennium Pharmaceuticals, Inc. (54) Eli Lilly and Company (51) Windmill Health Products, LLC (46) Bayer Aktiengesellschaft (45) SANOFI (43) Wyeth LLC (41) Pfizer Inc. (40) Bristol-Myers Squibb Company (39) Forest Laboratories, Inc. (34) Vital Health Pharmaceuticals, Inc. (31) MERCK SHARP & DOHME CORP. (28) Primary Investments Group Limited (28) S. C. Johnson & Son, Inc. (28) Futurebiotics, LLC (26) MONSTER ENERGY COMPANY (21) Hansen Beverage Company (19) Scott Riddell (17)Popular publication dates
Apr. 19, 2011 Mar. 08, 2011 Mar. 15, 2011 Mar. 22, 2011 Nov. 16, 2010 Mar. 29, 2011 Apr. 12, 2011 Oct. 19, 2010 Oct. 26, 2010 Apr. 26, 2011 Feb. 15, 2011 Oct. 05, 2010 Oct. 12, 2010 Jan. 25, 2011 Sep. 21, 2010 Jan. 11, 2011 Feb. 22, 2011 Nov. 23, 2010 Sep. 28, 2010 Apr. 05, 2011Similar brands
